investordatabase.org

Axil Capital Partners

axilcapital.com Direct investor

Axil Capital is a venture capital firm established in 2017 as a spinoff from Mizuho Securities, investing in life sciences companies from seed to crossover stage across regions and subsectors. It backs biopharmaceuticals, platform technologies, medical devices, digital health and healthcare services.

Axil Capital Partners is a venture capital firm headquartered in Japan, founded in 2017. It invests directly in companies, from seed to growth, in biopharmaceuticals, platform technologies, medical devices and digital health. 30 portfolio companies, as it reports.

“Axil Capital is a global venture capital firm investing in biomedical & healthcare technology.”

— Axil Capital Partners, own website
Layer
Direct investor
Type
Venture capital
Stage
Seed – Growth
Headquarters
Japan
Invests in
global
Sectors
biopharmaceuticals, platform technologies, medical devices, digital health, healthcare services, life sciences
Founded
2017
Portfolio
30 companies

Team, as Axil Capital Partners publishes it

  • Fred Shane Managing Partner
  • Hiroshi Gonaikawa Partner
  • Yoshitake Maeda, PhD Venture Partner
  • Rick Tsai, DMD, MD Venture Partner
  • Joon Paek, PhD, MBA Principal
  • Kenji Maekubo, MS Principal
  • Akihisa Seita, PhD Principal
  • Yuji Onizawa, PhD Principal
  • Itaru Hasegawa Head of Compliance & Administration
  • Tetsuji Nakajima Manager of IT
  • Miyuki Kamei Office Manager

Names and roles exactly as listed on axilcapital.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Axil Capital Partners publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 15377 · added 2026-10-20 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under